OVID THERAPEUTICS DL-,001 earnings per share and revenue

1OT earnings per share for the last quarter are -0.16 EUR whereas the estimation was -0.21 EUR which accounts for 23.93% surprise. Företagets omsättning för samma period uppgår till 137.16 k EUR trots den uppskattade siffran 48.26 k EUR. Estimated earnings per share for the next quarter are -0.21 EUR, and revenue is expected to reach 57.01 k EUR. Also watch annual changes over time to get a bigger picture of 1OT earnings per share and revenue dynamics.